RecruitingNot ApplicableNCT07710820
A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers
A Multi-Site Two-Arm Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Combustible Cigarette Smokers
Sponsor
RAI Services Company
Enrollment
1,060 participants
Start Date
Jul 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate the rate of end of study complete cigarette reduction in health adult consumers of cigarettes when given access to a heated tobacco product (HTP). The primary study objective is to evaluate the impact of access to HTP Device 1 or HTP Device 2 and a single stick variant on the rate of final 7-day abstinence from smoking cigarettes among U.S. adult smokers at the end of a 3-month study period.
Eligibility
Min Age: 21 YearsMax Age: 65 Years
Inclusion Criteria11
- Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.
- Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent, verified with government-issued identification.
- All female (assigned at birth) candidate participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at the SEV that they are not pregnant or intending to become pregnant. Note: Participants who identify as "intersex" or "unknown" during screening, will be required to take a pregnancy test if they wish to take one.
- Currently smoke at least five combustible cigarettes on smoking days in the past 30 days.
- Smoke combustible cigarettes on 15 or more of the past 30 days.
- Smoked at least 100 factory-made filtered menthol and/or non-menthol combustible cigarettes in their lifetime prior to the Site Enrollment Visit.
- Must indicate a neutral/positive intention to use at least one stick variant at the Site Enrollment Visit.
- Own a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications.
- Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF.
- Must try all four stick variants during the 1-week product trial period.
- Must indicate a neutral/positive intention to use at least one stick variant following the product trial period.
Exclusion Criteria11
- Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report.
- Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children.
- Female participants who self-report not using adequate methods to prevent pregnancy.
- Persons with pacemakers or other embedded electronic medical devices fitted.
- Participants who self-report having an unstable heart condition, severe hypertension, or diabetes.
- Individuals who respond with 'Poor' or 'Don't know' to general physical or mental health.
- Participants who have used electronic nicotine delivery system (ENDS), nicotine pouches, HTP or smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, other combustible tobacco/nicotine products, and other oral nicotine products (tablets, gums, and lozenges) on 5 or more days in the past 30 days.
- Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days.
- Employee of a company that manufactures tobacco or HTPs.
- Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or HTPs.
- Have taken part in a tobacco/nicotine research study in the past 30 days.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHER31237616
Tobacco Flavor #1
OTHER31237617
Tobacco Flavor #2
OTHER31237571
Menthol #1
OTHER31237581
Menthol #2
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07710820
Related Trials
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
NCT071661202 locations
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
NCT0722384027 locations
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
NCT070899011 location
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
NCT047838571 location
Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE
NCT069910621 location